Abstract Fibroblast growth factor 21 (FGF21) is a member of the endocrine FGF family that
acts as a metabolic regulator of both glucose and lipid metabolism. Similar to fibroblast …

We provide an overview of the evidence for an erythropoietin-fibroblast growth factor 23
(FGF23) signaling pathway directly influencing erythroid cells in the bone marrow. We …

Skeletal mineralization is initiated in matrix vesicles (MVs), the small extracellular vesicles
derived from osteoblasts and chondrocytes. Calcium and inorganic phosphate (Pi) taken up …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in
several developed countries, ranging from simple non-alcoholic fatty liver (NAFL) to non …

Following the serendipitous discovery of the ageing suppressor, αKlotho (αKl), several
decades ago, a growing body of evidence has defined a pivotal role for its various forms in …

Abstract FGF21 (fibroblast growth factor 21) is a regulator of metabolism and performs an
important role in glucose and lipid metabolism and the maintenance of energy balance …

Scope To study the effects of Maresin 1 (MaR1), a docosahexaenoic‐acid‐derived lipid
mediator, on fibroblast growth factor 21 (FGF21) production and to characterize the tissue …

Chronic pancreatitis (CP) is a progressive, irreversible inflammatory and fibrotic disease.
The characteristics of this disease are progressive inflammation, acinar atrophy and fibrosis …

Fibroblast growth factors (FGFs) are pleiotropic molecules exerting autocrine, intracrine and
paracrine functions via activating four tyrosine kinase FGF receptors (FGFR), which further …

Dysregulated actions of bone-derived phosphaturic hormone fibroblast growth factor 23
(FGF23) result in several inherited diseases, such as X-linked hypophosphatemia (XLH) …